Financial statements Pharma Odyn
Balance sheet data of PHARMA ODYN
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|---|
| Total assets | 9 544 729,90 | 9 752 599,33 | 9 075 408,57 | 8 325 798,77 | 5 002 582,88 | 5 536 783,23 |
| A. Fixed assets | 5 928 421,57 | 5 904 039,06 | 5 085 756,54 | 4 499 846,34 | 1 613 666,52 | 1 580 945,95 |
| B. Current assets | 3 583 245,71 | 3 815 497,65 | 3 956 589,41 | 3 792 889,81 | 3 388 916,36 | 3 955 837,28 |
| C. Share capital contributions (basic funds) | 33 062,62 | 33 062,62 | 33 062,62 | 33 062,62 | - | - |
| D. Own shares (stocks) | - | - | - | - | - | - |
| Total liabilities | 9 544 729,90 | 9 752 599,33 | 9 075 408,57 | 8 325 798,77 | 5 002 582,88 | 5 536 783,23 |
| A. Equity | -6 967 174,57 | -9 241 555,89 | -11 836 994,68 | -13 083 449,38 | -18 697 890,52 | -18 468 026,64 |
| B. Liabilities and provisions for liabilities | 16 511 904,47 | 18 994 155,22 | 20 912 403,25 | 21 409 248,15 | 23 700 473,40 | 24 004 809,87 |
| I. Long-term liabilities | 13 922 436,60 | 16 599 404,02 | 16 894 089,37 | 17 574 356,20 | 18 651 048,76 | 19 781 287,02 |
| II. Short-term liabilities | 2 426 075,01 | 2 118 173,01 | 3 674 494,44 | 3 346 006,29 | 2 913 329,81 | 3 342 577,35 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.